Atlas Trials

BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer

Clinical trial NCT03695250 · TERMINATED

Trial details

NCT number
NCT03695250
Sponsor
Edward Kim
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8Stage IVA Hepatocellular Carcinoma AJCC v8Stage IVB Hepatocellular Carcinoma AJCC v8Unresectable Hepatocellular Carcinoma
Start date
2018-10-16
Primary completion
2020-11-24
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.